| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 112.65▼ | 112.45▼ | 112.03▲ | 109.56▲ | 114.62▼ |
| MA10 | 112.78▼ | 111.91▲ | 111.09▲ | 113.37▼ | 108.21▲ |
| MA20 | 112.50▼ | 110.83▲ | 109.60▲ | 114.76▼ | 87.82▲ |
| MA50 | 111.35▲ | 109.23▲ | 111.26▲ | 105.41▲ | 75.36▲ |
| MA100 | 109.68▲ | 112.20▲ | 113.86▼ | 86.07▲ | 58.64▲ |
| MA200 | 110.12▲ | 113.92▼ | 117.70▼ | 76.30▲ | 39.11▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.124▼ | 0.185▲ | 0.569▲ | -1.742▼ | 2.664▲ |
| RSI | 51.536▲ | 61.059▲ | 57.271▲ | 50.013▲ | 64.797▲ |
| STOCH | 51.409 | 84.305▲ | 86.824▲ | 21.677 | 74.646 |
| WILL %R | -78.423▼ | -23.049▲ | -16.696▲ | -53.810 | -29.647 |
| CCI | -152.499▼ | 90.650 | 117.331▲ | -51.471 | 39.670 |
|
Monday, February 02, 2015 05:53 PM
After the first day of trading, the stock closed at $11.01. Ascendis Pharma A/S (NASDAQ: ASND) offered 6 million shares on January 28 at $18. After the first day of trading, the stock closed at $18.83 ...
|
|
Tuesday, January 27, 2015 03:56 PM
Details for these IPOs are listed below. The details and times of IPOs are subject to change. Ascendis Pharma A/S (NASDAQ: ASND) is a biotech company developing improved versions of existing drugs. ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/04/19 | 109.81 | 113.24 | 109.505 | 112.295 | 288,394 |
| 22/04/19 | 107.75 | 111.54 | 106.75 | 109.13 | 238,345 |
| 18/04/19 | 107.20 | 109.00 | 105.02 | 107.75 | 175,041 |
| 17/04/19 | 111.81 | 112.00 | 105.50 | 107.11 | 325,674 |
| 16/04/19 | 113.94 | 114.33 | 110.80 | 111.54 | 235,275 |
| 15/04/19 | 117.00 | 117.80 | 110.85 | 113.08 | 247,156 |
| 12/04/19 | 117.20 | 119.075 | 115.77 | 116.82 | 204,464 |
| 11/04/19 | 120.20 | 120.20 | 115.05 | 116.21 | 147,879 |
| 10/04/19 | 119.42 | 120.77 | 117.76 | 120.60 | 186,483 |
| 09/04/19 | 113.70 | 119.31 | 113.44 | 119.13 | 264,103 |
|
|
||||
|
|
||||
|
|
||||
|
|